Clinical Research Directory
Browse clinical research sites, groups, and studies.
2 clinical studies listed.
Filters:
Tundra lists 2 Advanced Solid Tumors (Phase 1) clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07259889
Safety and Tolerability Evaluation of CEL001 Injection in Advanced Solid Tumors
This study is the first human, open label, dose escalation, and expansion phase I clinical trial aimed at evaluating the safety, tolerability, preliminary efficacy, pharmacokinetic characteristics, biomarker changes, and immunogenicity of CEL001 injection in the treatment of advanced solid tumors.
Gender: All
Ages: 18 Years - Any
Updated: 2025-12-02
NCT06752447
A Phase I Study OfLNF2007 Monotherapy in Patients with Advanced Solid Tumors
A non-randomized, open-ended, phase I dose-escalation and dose-expansion study was designed to evaluate the safety, tolerability, antitumor efficacy, PK and immunogenic characteristics of LNF2007 in patients with advanced solid tumors
Gender: All
Ages: 18 Years - 75 Years
Updated: 2024-12-30